Bayesian GWAS — Bayesian Genome-Wide Association Study
Bayesian Genome-Wide Association Study · Also known as: Bayesian GWAS, Bayesian genome-wide association analysis, Bayesian GWA study, BF-GWAS
Bayesian GWAS applies Bayesian statistical inference to genome-wide association studies, replacing classical p-value thresholds with Bayes factors and posterior probabilities. This framework naturally incorporates prior knowledge about effect sizes and variant frequencies, quantifies evidence for association on a continuous scale, and supports principled fine-mapping of causal variants within associated loci. It is widely used in complex trait genetics, population genomics, and translational research where uncertainty quantification and multi-variant modeling matter.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use Bayesian GWAS when you need probabilistic, continuously scaled evidence for genetic associations rather than binary significant/non-significant calls; when the goal includes fine-mapping to identify probable causal variants within associated loci; when integrating functional genomic priors (e.g., variant annotation, LD structure) into the association analysis; or when comparing evidence across studies or combining summary statistics without individual-level data access. It is especially valuable for rare-variant analyses and multi-ancestry studies where classical p-value calibration is problematic. Do NOT use Bayesian GWAS as a substitute when you simply need a standard frequentist GWAS for regulatory or pre-specified confirmatory analysis — classical approaches remain the norm for primary discovery reporting in most consortium settings. Avoid it when prior specification is arbitrary and results are highly prior-sensitive without sensitivity analyses.
Strengths & limitations
- Produces posterior probabilities of association that are directly interpretable and actionable, unlike p-values.
- Naturally incorporates prior information about effect sizes, variant function, and LD structure.
- Enables principled fine-mapping with credible sets, often reducing the causal candidate list from hundreds of LD-linked variants to tens.
- Operates on summary statistics, enabling meta-analysis and multi-study integration without sharing individual-level data.
- Handles multiple causal signals within a locus (multi-causal fine-mapping) more explicitly than stepwise conditional approaches.
- Results are sensitive to the choice of prior distributions for effect sizes and prior probability of association; poorly calibrated priors yield misleading PPAs.
- Computation at true genome-wide scale (millions of SNPs, multi-variant models) is demanding; approximate methods trade off accuracy for speed.
- Credible sets assume a single causal variant per locus in many implementations; violations inflate uncertainty.
- Less familiar to reviewers and consortia accustomed to p-value thresholds, potentially complicating publication and replication reporting.
Frequently asked
How is Bayesian GWAS different from standard GWAS?
Standard GWAS tests each SNP with a frequentist regression and reports a p-value; a threshold (typically 5×10⁻⁸) declares significance. Bayesian GWAS computes a Bayes factor and posterior probability for each SNP, quantifying how much more likely the data are under association versus no association, and incorporating a prior. The output is a ranked probability list rather than a binary significant/non-significant decision, enabling finer prioritization and uncertainty quantification.
Do I need individual-level genotype data to run Bayesian GWAS?
No. Wakefield's approximate Bayes factor (ABF) is computed from GWAS summary statistics — the estimated effect size (beta or log-OR) and its standard error from standard regression. This makes Bayesian fine-mapping accessible from publicly released GWAS summary data without accessing the original cohort.
What is a credible set and how does it differ from a confidence interval?
A 95% credible set is the smallest collection of variants whose posterior probabilities of being causal sum to at least 0.95. It is directly interpretable as 'there is a 95% posterior probability that the true causal variant is in this set.' A classical confidence interval is a frequentist construct that does not carry this direct probability interpretation. Credible sets from well-calibrated Bayesian fine-mapping are often far smaller than the full LD block.
Which tools implement Bayesian GWAS and fine-mapping?
Widely used tools include FINEMAP and SuSiE for multi-causal fine-mapping; CAVIAR and CAVIARBF; coloc and HyPrColoc for colocalisation; and PRS-CS or LDpred2 for Bayesian polygenic scoring. Approximate Bayes factors can be computed from any standard GWAS summary output with simple post-processing scripts.
How do I choose the prior probability of association pi?
A common default is pi = 1 / (number of independent variants tested), placing a prior expectation of roughly one causal variant genome-wide — conservatively small. Empirical estimates from large GWAS suggest pi in the range 10⁻⁵ to 10⁻⁴ for common complex traits. Always report sensitivity analyses across a range of pi values to show that conclusions are robust to prior choice.
Sources
- Stephens, M., & Balding, D. J. (2009). Bayesian statistical methods for genetic association studies. Nature Reviews Genetics, 10(10), 681–690. DOI: 10.1038/nrg2615 ↗
- Wakefield, J. (2009). Bayes factors for genome-wide association studies: comparison with P-values. Genetic Epidemiology, 33(1), 79–86. DOI: 10.1002/gepi.20359 ↗
How to cite this page
ScholarGate. (2026, June 3). Bayesian Genome-Wide Association Study. ScholarGate. https://scholargate.app/en/bioinformatics/bayesian-gwas
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Bayesian eQTL analysisBioinformatics↔ compare
- Bayesian single-cell RNA-seq analysisBioinformatics↔ compare
- Genome-wide association studyBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- Polygenic Risk ScoreGenetics↔ compare